Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines (Q38844134)

6 September 2017

Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines (English)

1 reference

6 September 2017

1 reference

hepatocellular carcinoma

1 reference

Zhikui Cheng

1

1 reference

6 September 2017

Ge Sun

2

1 reference

6 September 2017

Wei Guo

3

1 reference

6 September 2017

Yayun Huang

4

1 reference

6 September 2017

Weihua Sun

5

1 reference

6 September 2017

Fei Zhao

6

1 reference

6 September 2017

Kanghong Hu

7

1 reference

6 September 2017

8 August 2015

1 reference

6 September 2017

1 reference

6 September 2017

30

1 reference

6 September 2017

261-268

1 reference

6 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s12250-015-3584-5

6 September 2017

0 references

cites work

Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Pathogenesis of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Quercetin reduces susceptibility to influenza infection following stressful exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Evidence for multiple distinct interactions between hepatitis B virus P protein and its cognate RNA encapsidation signal during initiation of reverse transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Control of cccDNA function in hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Hepatitis B viruses: reverse transcription a different way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Inhibitors of the heat shock response: biology and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

The replication cycle of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Treatment of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-015-3584-5

Hepatitis B virus infection

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Antiviral effect of flavonoids on human viruses

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly

1 reference

12 December 2020

In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.

1 reference

12 December 2020

The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway.

1 reference

12 December 2020

10.1007/S12250-015-3584-5

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference